These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23085755)

  • 1. Mesenchymal stem cells promote growth and angiogenesis of tumors in mice.
    Huang WH; Chang MC; Tsai KS; Hung MC; Chen HL; Hung SC
    Oncogene; 2013 Sep; 32(37):4343-54. PubMed ID: 23085755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells promote formation of colorectal tumors in mice.
    Tsai KS; Yang SH; Lei YP; Tsai CC; Chen HW; Hsu CY; Chen LL; Wang HW; Miller SA; Chiou SH; Hung MC; Hung SC
    Gastroenterology; 2011 Sep; 141(3):1046-56. PubMed ID: 21699785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration.
    De Luca A; Lamura L; Gallo M; Maffia V; Normanno N
    J Cell Biochem; 2012 Nov; 113(11):3363-70. PubMed ID: 22644871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway.
    Hsu HS; Lin JH; Hsu TW; Su K; Wang CW; Yang KY; Chiou SH; Hung SC
    Lung Cancer; 2012 Feb; 75(2):167-77. PubMed ID: 21802163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects.
    Shangguan L; Ti X; Krause U; Hai B; Zhao Y; Yang Z; Liu F
    Stem Cells; 2012 Dec; 30(12):2810-9. PubMed ID: 23034983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer.
    Shinagawa K; Kitadai Y; Tanaka M; Sumida T; Onoyama M; Ohnishi M; Ohara E; Higashi Y; Tanaka S; Yasui W; Chayama K
    Int J Cancer; 2013 Feb; 132(4):813-23. PubMed ID: 22821812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contextual niche signals towards colorectal tumor progression by mesenchymal stem cell in the mouse xenograft model.
    Nakagaki S; Arimura Y; Nagaishi K; Isshiki H; Nasuno M; Watanabe S; Idogawa M; Yamashita K; Naishiro Y; Adachi Y; Suzuki H; Fujimiya M; Imai K; Shinomura Y
    J Gastroenterol; 2015 Sep; 50(9):962-74. PubMed ID: 25680886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitation of in vivo models investigating angiogenesis in breast cancer.
    Gehmert S; Gehmert S; Bai X; Klein S; Ortmann O; Prantl L
    Clin Hemorheol Microcirc; 2011; 49(1-4):519-26. PubMed ID: 22214723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental therapy for lung cancer: umbilical cord-derived mesenchymal stem cell-mediated interleukin-24 delivery.
    Zhang X; Zhang L; Xu W; Qian H; Ye S; Zhu W; Cao H; Yan Y; Li W; Wang M; Wang W; Zhang R
    Curr Cancer Drug Targets; 2013 Jan; 13(1):92-102. PubMed ID: 23170786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
    McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
    Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal Stem Cells Engineered to Secrete Pigment Epithelium-Derived Factor Inhibit Tumor Metastasis and the Formation of Malignant Ascites in a Murine Colorectal Peritoneal Carcinomatosis Model.
    Yang L; Zhang Y; Cheng L; Yue D; Ma J; Zhao D; Hou X; Xiang R; Cheng P
    Hum Gene Ther; 2016 Mar; 27(3):267-77. PubMed ID: 26756933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells.
    De Luca A; Gallo M; Aldinucci D; Ribatti D; Lamura L; D'Alessio A; De Filippi R; Pinto A; Normanno N
    J Cell Physiol; 2011 Aug; 226(8):2131-8. PubMed ID: 21520065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase.
    Sun ZJ; Chen G; Zhang W; Hu X; Huang CF; Wang YF; Jia J; Zhao YF
    J Pharmacol Exp Ther; 2010 Aug; 334(2):500-12. PubMed ID: 20484154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
    Tu B; Du L; Fan QM; Tang Z; Tang TT
    Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway.
    Yan XL; Fu CJ; Chen L; Qin JH; Zeng Q; Yuan HF; Nan X; Chen HX; Zhou JN; Lin YL; Zhang XM; Yu CZ; Yue W; Pei XT
    Breast Cancer Res Treat; 2012 Feb; 132(1):153-64. PubMed ID: 21584665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and activity of SRC regulate interleukin-8 expression in pancreatic adenocarcinoma cells: implications for angiogenesis.
    Trevino JG; Summy JM; Gray MJ; Nilsson MB; Lesslie DP; Baker CH; Gallick GE
    Cancer Res; 2005 Aug; 65(16):7214-22. PubMed ID: 16103072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
    Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
    Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.
    Nör JE; Christensen J; Liu J; Peters M; Mooney DJ; Strieter RM; Polverini PJ
    Cancer Res; 2001 Mar; 61(5):2183-8. PubMed ID: 11280784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.